Findings

What do systematic reviews say?

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

McKenzie therapy vs other interventions

Pain intensity various scales short‐term · patients with non‐specific acute and subacute low back pain

The review found no eligible studies for this question.

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

McKenzie therapy vs other interventions

Pain: intermediate‐term · patients with non‐specific acute and subacute low back pain

The review found no eligible studies for this question.

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

McKenzie therapy vs other interventions

Disability Multiple scales (0 to 100) Short‐term · patients with non‐specific acute and subacute low back pain

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

McKenzie therapy vs other interventions

Disability (intermediate‐term) RMDQ. Scale from: 0 to 24. · patients with non‐specific acute and subacute low back pain

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 25 participants
Very low

McKenzie therapy vs other interventions

Adverse events · patients with non‐specific acute and subacute low back pain

The review found no eligible studies for this question.

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

McKenzie therapy vs minimal intervention

Pain: intermediate‐term · patients with non‐specific acute and subacute low back pain

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 180 participants
Low

McKenzie therapy vs minimal intervention

Disability 1 week (immediate term) (RMDQ 0 to 24) · patients with non‐specific acute and subacute low back pain

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 328 participants
Low

McKenzie therapy vs minimal intervention

Disability (intermediate‐term) RMDQ. Scale from: 0 to 24. · patients with non‐specific acute and subacute low back pain

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 180 participants
Low

McKenzie therapy vs minimal intervention

Adverse events · patients with non‐specific acute and subacute low back pain

The review found no eligible studies for this question.

1 finding from 1 review

The McKenzie method for (sub)acute non‐specific low back pain 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Combined steroid and antibiotic therapy vs antibiotics alone

Outcomes* · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

The review found no eligible studies for this question.

1 finding from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Combined steroid and antibiotic therapy vs antibiotics alone

Complete resolution of endophthalmitis at 3 months' · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

It is very uncertain whether combined steroid and antibiotic therapy changes complete resolution of endophthalmitis at 3 months' compared with antibiotics alone (very low certainty).

1 finding from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
RR 1.08 [0.8, 1.45]
1 study · 32 participants
Very low

Combined steroid and antibiotic therapy vs antibiotics alone

Visual acuity · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

Combined steroid and antibiotic therapy may leads to higher visual acuity 6/6 to 6/18 at 3 months' compared with antibiotics alone (low certainty).

2 findings from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
RR 1.95 [1.05, 3.6]
2 studies · 60 participants
Low
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
RR 1.12 [0.92, 1.37]
2 studies · 195 participants
Low

Combined steroid and antibiotic therapy vs antibiotics alone

Improvement in visual acuity at 3 months' · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

The review found no eligible studies for this question.

1 finding from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Combined steroid and antibiotic therapy vs antibiotics alone

Intraocular pressure ( · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

1 finding from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 167 participants
Low

Combined steroid and antibiotic therapy vs antibiotics alone

Adverse events at 3 to 12 months' · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

Combined steroid and antibiotic therapy showed no clear difference in adverse events at 3 to 12 months' compared with antibiotics alone (low certainty).

1 finding from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
RR 1.41 [0.53, 3.74]
3 studies · 227 participants
Low

Combined steroid and antibiotic therapy vs antibiotics alone

Costs · eyes with acute endophthalmitis following an intraocular procedure (e.g. surgery, intravitreous injection)

The review found no eligible studies for this question.

1 finding from 1 review

Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Fast‐acting nicotine replacement therapy vs nicotine patch

Smoking cessation · people who smoke

Fast‐acting nicotine replacement therapy showed no clear difference in smoking cessation compared with nicotine patch (high certainty).

1 finding from 1 review

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
RR 0.9 [0.77, 1.05]
8 studies · 3319 participants
High

Fast‐acting nicotine replacement therapy vs nicotine patch

Overall serious adverse events · people who smoke

1 finding from 1 review

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1252 participants
Very low

Fast‐acting nicotine replacement therapy vs nicotine patch

Treatment withdrawal · people who smoke

It is very uncertain whether fast‐acting nicotine replacement therapy changes treatment withdrawals compared with nicotine patch (very low certainty).

1 finding from 1 review

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation 2023 · Cochrane Headline outcomes only
RR 4.23 [1.54, 11.63]
3 studies · 1482 participants
Very low

Myofunctional therapy plus nasal washing vs Nasal washing alone

AHI score reduction to below 5 points. · obstructive sleep apnoea

Myofunctional therapy plus nasal washing showed no clear difference in AHI score reduction to below 5 points. compared with nasal washing alone (low certainty).

1 finding from 1 review

Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea 2020 · Cochrane Headline outcomes only
OR 12.5 [0.84, 186.3]
1 study · 13 participants
Low